deltatrials
Completed PHASE3 NCT00412854

Study to Assess Safety & Immunogenicity of GSK Biologicals' DTPa/Hib Vaccine vs Separate Administration of DTPa and Hib.

Phase IIIb, Multicentre Study to Assess Safety & Immunogenicity of GSK Biologicals' Combined DTPa/Hib (Infanrix/Hib) Vaccine vs Separate Administration of DTPa (Infanrix) & Hib (Hiberix) Vaccines in Healthy Infants 3,4,&5 Months of Age as Compared With the Separate Administration of DTPa and Hib Vaccines at Different Injection Sites.

Sponsor: GlaxoSmithKline

Conditions Acellular Pertussis Diphtheria Tetanus
Interventions Hiberix Infanrix Infanrix™/Hib
Updated 8 times since 2017 Last updated: Apr 26, 2018 Started: Jan 3, 2007 Primary completion: Jun 1, 2007 Completion: Jun 25, 2007

This PHASE3 trial investigates Acellular Pertussis and Diphtheria and is currently completed. GlaxoSmithKline leads this study, which shows 8 recorded versions since 2007 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Change History

8 versions recorded

  1. Sep 2024 — Present [monthly]

    Completed PHASE3

  2. Jul 2024 — Sep 2024 [monthly]

    Completed PHASE3

  3. Dec 2021 — Jul 2024 [monthly]

    Completed PHASE3

  4. Jan 2021 — Dec 2021 [monthly]

    Completed PHASE3

  5. Jul 2018 — Jan 2021 [monthly]

    Completed PHASE3

▶ Show 3 earlier versions

  1. Jun 2018 — Jul 2018 [monthly]

    Completed PHASE3

  2. Feb 2017 — Jun 2018 [monthly]

    Completed PHASE3

  3. Jan 2017 — Feb 2017 [monthly]

    Completed PHASE3

    First recorded

Jan 2007

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • GlaxoSmithKline
Data source: GlaxoSmithKline

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

  • • Mengshan, China
  • • Wuzhou, China